LogicBio Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2020 to Q3 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
LogicBio Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q3 2022.
  • LogicBio Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2022 was -241 %, a 74.2% increase year-over-year.
  • LogicBio Therapeutics, Inc. annual Operating Margin for 2021 was -721 %, a 21% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -241 +692 +74.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -296 +965 +76.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -456 +656 +59% Jan 1, 2022 Mar 31, 2022
Q4 2021 -721 +192 +21% Oct 1, 2021 Dec 31, 2021
Q3 2021 -933 Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.26K Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.11K Jan 1, 2021 Mar 31, 2021
Q4 2020 -912 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.